RxDoctor Payments Data

Phillip Khalil, DO

Otolaryngology/Facial Plastic Surgery · Stow, OHNPI 1467403485

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $847, more than ten times the $68 reported in 2019.

$2,924in general payments, 2019–2025

Across 91 payments — averaging $32.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$570
  • Regeneron Healthcare Solutions, Inc.$523
  • Inspire Medical Systems, Inc.$427
  • Optinose US, Inc.$359
  • Sanofi$354
  • GSK$245
  • plus $447 from 9 others

What the payments were for

  • Food & beverage$2,924100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,924 in reported general payments places this provider in the 70th percentile of 29 otolaryngology/facial plastic surgery providers in Ohio.

See all otolaryngology/facial plastic surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$64,325
Medicare patients
203
Services billed
478

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl102$2,271
Mometasone Furoate43$1,622
Ipratropium Bromide48$1,169
Fluticasone Propionate94$1,122
Pantoprazole Sodium108$681
Mupirocin25$198
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$165
Doxycycline Hyclate11$93
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid18$72

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Stow

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →